Nyumbani › Saratani ya Thyroid › Texas
Majaribio ya kliniki ya Saratani ya Thyroid katika jimbo la Texas
Masomo 15 ya Saratani ya Thyroid yanatafuta washiriki katika vituo vya jimbo la Texas.
Miji katika jimbo la Texas
Maandishi rasmi ya utafiti (Kiingereza)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- The Don and Sybil Harrington Cancer Center, Amarillo
- UT MD Anderson Cancer Center, Houston
- Audie L Murphy VA Hospital, San Antonio
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
Umri 40 hadi 75 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT05334069DESTINY-PANTUMOUR04
- Research Site, Dallas
InaajiriUtafiti wa uchunguzi
Umri 18 hadi 130 · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT07124000Global Real World Data in Patients With Advanced Thyroid Cancer on Standard of Care and Specialized Interventions- Registry of Oncologic Outcomes With Testing and Treatment.
- MD Anderson Cancer Center, Houston
InaajiriUtafiti wa uchunguzi
Umri 18 na zaidi · Jinsia zote · Imesasishwa 18 Sep 2026 · NCT06507878Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- MD Anderson Cancer Center, Houston
- START San Antonio, San Antonio
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 16 Sep 2026 · NCT05786924Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma
- The University of Texas M. D. Anderson Cancer Center, Houston
Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 11 Sep 2026 · NCT07218315Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery
- MD Anderson Cancer Center, Houston
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 4 Sep 2026 · NCT06959511Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
- MD Anderson Cancer Center, Houston
InaajiriHatua 2
Umri 2 hadi 25 · Jinsia zote · Imesasishwa 24 Jul 2026 · NCT06458036A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- UT Southwestern Medical Center, Dallas
- MD Anderson Cancer Center, Houston
InaajiriHatua 1/2
Umri 12 na zaidi · Jinsia zote · Imesasishwa 27 Mei 2026 · NCT03093116An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy
- M D Anderson Cancer Center, Houston
InaajiriHatua 1Wajitolea wenye afya wanakaribishwa
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Mei 2026 · NCT04589624Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- MD Anderson Cancer Center, Houston
- NEXT Oncology, San Antonio
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 6 Mei 2026 · NCT06239194Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
- M D Anderson Cancer Center, Houston
Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 15 Apr 2026 · NCT04693377cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Elligo Health Research, Inc., Austin
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
Umri 40 na zaidi · Jinsia zote · Imesasishwa 20 Jan 2026 · NCT05366881Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
- MD Anderson Cancer Center, Houston
InaajiriHatua 2
Umri 2 hadi 99 · Jinsia zote · Imesasishwa 14 Nov 2025 · NCT05783323Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
- University of Texas Health Science Center, San Antonio
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
Umri wote · Jinsia zote · Imesasishwa 15 Okt 2025 · NCT03160274Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC
- MD Anderson Cancer Center, Houston
InaajiriHatua 2
Umri 12 na zaidi · Jinsia zote · Imesasishwa 12 Des 2024 · NCT05668962Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.